CEO, Damian Wheeler Ph.D., Presents at the BIO-SEE 2023 Webinar Series

Translucence Biosystems
March 23, 2023

Damian Wheeler Ph.D., CEO of Translucence Biosystems, presented the company's innovative approach to brain-wide single-cell imaging in a talk entitled "Brain-wide single-cell resolution imaging and machine learning-enabled quantification" at the recent BIO-SEE 2023 Webinar Series hosted by The Orbeli Physiology Institute.

Recent advances in tissue clearing and light sheet imaging have paved the way for brain-wide, cellular-resolution immunostaining. Translucence Biosystems is at the forefront of these developments, developing hardware, software, and reagent kits that enable neuroscientists to access the intricate anatomy of the whole intact brain, providing them with unbiased and complete views of brain anatomy and function.

During his presentation, Dr. Wheeler introduced the Translucence Neuronal Activity Tissue Clearing Kit, the latest addition to the Translucence Biosystems ecosystem. This new reagent kit allows neuroscientists to gain insight into brain-wide, cellular resolution measurements of neuronal activity using the immediate-early gene products Npas4 and cFos.

For a comprehensive overview of Translucence Biosystems' methodology, products, and services, we encourage you to watch the recording of Dr. Wheeler's talk to gain a deeper understanding of the exciting developments in brain-wide single-cell imaging and the potential impact on neuroscience research.

To learn more, please watch the recording of Dr. Wheeler's presentation below.

Ask your question

Send us your questions and we will get back to you as soon as possible

Thank you! Your submission has been received!
Something went wrong while submitting the form.
Please, contact via us direct email info@translucencebio.comand

Recent news

January 31, 2023

Translucence Biosystems Participates in Keystone Meeting on Drug Delivery to the Brain

Our team has been working with Lundbeck to monitor therapeutic antibody biodistribution in the brain using tissue clearing and light sheet imaging. Our CEO, Damian Wheeler, Ph.D. presented our findings in our poster titled the "Brain-Wide Cellular-Resolution Measurement of Antibody Therapeutics."
Translucence Biosystems
November 13, 2022

Translucence Biosystems Presents at SfN 2022

The Translucence team, including Nate Guanzon, Chase Redd, and CEO Damian Wheeler presented our BRAIN Initiative-funded work on whole-brain quantification neuronal activity with Npas4 and cFos at SfN 2022.
Translucence Biosystems
May 4, 2022

Co-Founder, Sunil Gandhi Ph.D., presents at the 8th Annual Bench to Bedside Symposium

Co-Founder, Sunil Gandhi Ph.D., presents at the 8th Annual Bench to Bedside Symposium hosted by the Gavin Herbert Eye Institute at the University of California, Irvine School of Medicine.
Angela Prvulovic